Tram Bui
Vice President of Investor Relations and Corporate Communications
Replay available
Halozyme Therapeutics, Inc. (NASDAQ: HALO) Q4 2025 earnings conference call, held 2026-01-28. Replay captured from the company's public earnings webcast.

Vice President of Investor Relations and Corporate Communications
President and Chief Executive Officer
Analyst, Morgan Stanley
Analyst, TD Cowan
Analyst, Evercore ISI
Analyst, Wells Fargo
Analyst, Leerink Partners
Analyst, JMP Securities
Watch the replay and follow the connected company analysis, news, and investor updates for Halozyme Therapeutics, Inc..
WEBVTT 00:00:01.246 -- 00:00:05.352 Good morning. My name is Eric and I will be your conference operator today. 00:00:05.352 -- 00:00:11.500 At this time, I would like to welcome everyone to Halozyme's investor conference call. 00:00:11.500 -- 00:00:14.745 After the speaker's remarks, there will be a question and answer session. 00:00:14.745 -- 00:00:19.191 If you would like to ask a question at this time, simply press star followed by the number 00:00:19.191 -- 00:00:23.497 one on your telephone keypad. If you would like to withdraw your question, press star 00:00:23.497 -- 00:00:25.259 one again. Please 00:00:25.259 -- 00:00:28.003 note this event is being recorded. 00:00:28.003 -- 00:00:33.223 I'll now turn the call over to Tram Bui, HALO-ZIM's Vice President 00:00:33.223 -- 00:00:37.128 of Investor Relations and Corporate Communications. 00:00:37.128 -- 00:00:39.488 Please go ahead. 00:00:39.611 -- 00:00:44.677 Thank you, Operator. Good morning and welcome to HALO-ZIM's Investor Conference Call. 00:00:44.677 -- 00:00:48.662 In addition to the press release issued earlier this morning, you can find a supplementary 00:00:48.662 -- 00:00:53.469 slide presentation that will be referenced during today's call in the Investor Relations 00:00:53.469 -- 00:00:56.853 section of our website. Leading the call will be Dr. 00:00:56.853 -- 00:01:01.676 Helen Torley, HALO-ZIM's President and Chief Executive Officer, We will provide an update 00:01:01.676 -- 00:01:06.804 on our business and provide preliminary 2025 revenue estimates in addition to an 00:01:06.804 -- 00:01:09.408 update to our 2026 to 2028 00:01:09.408 -- 00:01:11.311 financial guidance. 00:01:11.311 -- 00:01:15.597 On today's call, we will be making forward-looking statements as outlined on slide 2. 00:01:15.597 ...